{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:25:02Z","timestamp":1790673902152,"version":"4.1.0"},"reference-count":51,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,3,19]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>Methylation profiling identifies subgroups of SMZL with distinct biological features. Demethylating agents can reverse some of the adverse epigenetic alterations.<\/jats:p>","DOI":"10.1182\/blood-2014-08-596247","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T05:34:28Z","timestamp":1421991268000},"page":"1922-1931","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":57,"title":["DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features"],"prefix":"10.1182","volume":"125","author":[{"given":"Alberto J.","family":"Arribas","sequence":"first","affiliation":[{"name":"Lymphoma & Genomics Research Program, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rinaldi","sequence":"additional","affiliation":[{"name":"Lymphoma & Genomics Research Program, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afua A.","family":"Mensah","sequence":"additional","affiliation":[{"name":"Lymphoma & Genomics Research Program, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Kwee","sequence":"additional","affiliation":[{"name":"Lymphoma & Genomics Research Program, Institute of Oncology Research, Bellinzona, Switzerland;"},{"name":"Dalle Molle Institute for Artificial Intelligence, Manno, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4606-0637","authenticated-orcid":false,"given":"Luciano","family":"Cascione","sequence":"additional","affiliation":[{"name":"Lymphoma & Genomics Research Program, Institute of Oncology Research, Bellinzona, Switzerland;"},{"name":"Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloy F.","family":"Robles","sequence":"additional","affiliation":[{"name":"Division of Oncology, Center for Applied Medical Research, University of Navarra, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Martinez-Climent","sequence":"additional","affiliation":[{"name":"Division of Oncology, Center for Applied Medical Research, University of Navarra, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Oscier","sequence":"additional","affiliation":[{"name":"Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Arcaini","sequence":"additional","affiliation":[{"name":"Division of Hematology, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, University of Pavia, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Baldini","sequence":"additional","affiliation":[{"name":"Hematology\/Bone Marrow Transplantation Unit, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico Ca\u2019Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Marasca","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Oncology and Hematology, University of Modena and Reggio Emilia, Modena, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Thieblemont","sequence":"additional","affiliation":[{"name":"Hematology Laboratory and Service d\u2019Hemato-oncologie, Hopita\u00e9 Saint-Louis, Universit\u00e9 Paris Diderot, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josette","family":"Briere","sequence":"additional","affiliation":[{"name":"Hematology Laboratory and Service d\u2019Hemato-oncologie, Hopita\u00e9 Saint-Louis, Universit\u00e9 Paris Diderot, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Forconi","sequence":"additional","affiliation":[{"name":"Haematology Oncology Group, Cancer Sciences Unit, Cancer Research UK Centre, University of Southampton and Haematology Department, Southampton University Hospital Trust, Southampton, United Kingdom;"},{"name":"Division of Haematology, University of Siena, Siena, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zam\u00f2","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Hematology, University of Verona, Verona, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Bonifacio","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Hematology, University of Verona, Verona, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Mollejo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Virgen de la Salud, Toledo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Facchetti","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Brescia, I Servizio di Anatomia Patologica, Spedali Civili di Brescia, Brescia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Dirnhofer","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of Basel, Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[{"name":"Pathology Unit and Unit of Lymphoid Malignancies, San Raffaele H Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[{"name":"Herbert Irving Comprehensive Cancer Center, Department of Pathology and Cell Biology, Columbia University Medical Center and New York Presbyterian Hospital, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Piris","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Marques de Valdecilla, Santander, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Gaidano","sequence":"additional","affiliation":[{"name":"Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Zucca","sequence":"additional","affiliation":[{"name":"Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Rossi","sequence":"additional","affiliation":[{"name":"Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5637-8983","authenticated-orcid":false,"given":"Francesco","family":"Bertoni","sequence":"additional","affiliation":[{"name":"Lymphoma & Genomics Research Program, Institute of Oncology Research, Bellinzona, Switzerland;"},{"name":"Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111818203125500_B1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"5","key":"2019111818203125500_B2","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome.","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2019111818203125500_B3","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.","volume":"116","author":"Salido","year":"2010","journal-title":"Blood"},{"issue":"9","key":"2019111818203125500_B4","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.","volume":"209","author":"Rossi","year":"2012","journal-title":"J Exp Med"},{"issue":"9","key":"2019111818203125500_B5","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20120910","article-title":"Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.","volume":"209","author":"Kiel","year":"2012","journal-title":"J Exp Med"},{"issue":"12","key":"2019111818203125500_B6","doi-asserted-by":"crossref","first-page":"e83244","DOI":"10.1371\/journal.pone.0083244","article-title":"Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma.","volume":"8","author":"Parry","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"2019111818203125500_B7","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/leu.2013.365","article-title":"Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.","volume":"28","author":"Mart\u00ednez","year":"2014","journal-title":"Leukemia"},{"issue":"11","key":"2019111818203125500_B8","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2013-07-509885","article-title":"Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes.","volume":"123","author":"Chambwe","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2019111818203125500_B9","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/cts.12162","article-title":"Hypermethylation of p15 gene in diffuse - large B-cell lymphoma: association with less aggressiveness of the disease.","volume":"7","author":"Krajnovi\u0107","year":"2014","journal-title":"Clin Transl Sci"},{"issue":"4","key":"2019111818203125500_B10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jmoldx.2014.03.003","article-title":"Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker.","volume":"16","author":"Giachelia","year":"2014","journal-title":"J Mol Diagn"},{"issue":"21","key":"2019111818203125500_B11","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1182\/blood-2012-12-451799","article-title":"Mechanisms of epigenetic deregulation in lymphoid neoplasms.","volume":"121","author":"Jiang","year":"2013","journal-title":"Blood"},{"issue":"3","key":"2019111818203125500_B12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nchembio.1157","article-title":"Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain.","volume":"9","author":"James","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"10","key":"2019111818203125500_B13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nchembio.1331","article-title":"Targeted disruption of the EZH2-EED complex inhibits EZH2-dependent cancer.","volume":"9","author":"Kim","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"19","key":"2019111818203125500_B14","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1182\/blood-2013-07-517177","article-title":"The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.","volume":"123","author":"Zhang","year":"2014","journal-title":"Blood"},{"issue":"3","key":"2019111818203125500_B15","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.leu.2405068","article-title":"Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.","volume":"22","author":"Matutes","year":"2008","journal-title":"Leukemia"},{"issue":"2","key":"2019111818203125500_B16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/bjh.12515","article-title":"Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma.","volume":"163","author":"Rinaldi","year":"2013","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111818203125500_B17","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2141.2012.09226.x","article-title":"High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.","volume":"158","author":"Fresquet","year":"2012","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111818203125500_B18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2141.2010.08347.x","article-title":"Immunogenetics features and genomic lesions in splenic marginal zone lymphoma.","volume":"151","author":"Rinaldi","year":"2010","journal-title":"Br J Haematol"},{"issue":"7","key":"2019111818203125500_B19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/annonc\/mdi217","article-title":"In vitro activity of cyclin-dependent kinase inhibitor CYC202 (Seliciclib, R-roscovitine) in mantle cell lymphomas.","volume":"16","author":"Lacrima","year":"2005","journal-title":"Ann Oncol"},{"issue":"20","key":"2019111818203125500_B20","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1182\/blood-2011-02-336891","article-title":"HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL.","volume":"118","author":"Kalac","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111818203125500_B21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2217\/epi.09.14","article-title":"Genome-wide DNA methylation profiling using Infinium\u00ae assay.","volume":"1","author":"Bibikova","year":"2009","journal-title":"Epigenomics"},{"key":"2019111818203125500_B22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1471-2105-6-232","article-title":"EXPANDER\u2014an integrative program suite for microarray data analysis.","volume":"6","author":"Shamir","year":"2005","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"2019111818203125500_B23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.","volume":"4","author":"Huang","year":"2009","journal-title":"Nat Protoc"},{"issue":"43","key":"2019111818203125500_B24","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"2019111818203125500_B25","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0.","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"issue":"11","key":"2019111818203125500_B26","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"issue":"5","key":"2019111818203125500_B27","doi-asserted-by":"crossref","first-page":"R174","DOI":"10.1186\/ar4362","article-title":"Transcriptional landscapes of emerging autoimmunity: transient aberrations in the targeted tissue\u2019s extracellular milieu precede immune responses in Sj\u00f6gren\u2019s syndrome.","volume":"15","author":"Delaleu","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"2019111818203125500_B28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2144\/000112597","article-title":"MethylScreen: DNA methylation density monitoring using quantitative PCR.","volume":"43","author":"Holemon","year":"2007","journal-title":"Biotechniques"},{"issue":"12","key":"2019111818203125500_B29","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","article-title":"Splenic marginal zone lymphoma: a prognostic model for clinical use.","volume":"107","author":"Arcaini","year":"2006","journal-title":"Blood"},{"issue":"7","key":"2019111818203125500_B30","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/modpathol.2012.220","article-title":"Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling.","volume":"26","author":"Arribas","year":"2013","journal-title":"Mod Pathol"},{"issue":"18","key":"2019111818203125500_B31","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2011-06-359166","article-title":"Alteration of BIRC3 and multiple other NF-\u03baB pathway genes in splenic marginal zone lymphoma.","volume":"118","author":"Rossi","year":"2011","journal-title":"Blood"},{"issue":"20","key":"2019111818203125500_B32","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1182\/blood-2008-08-174110","article-title":"The NF-KB negative regulator TNFAIP3 (A20) is commonly inactivated by somatic mutations and genomic deletions in marginal zone B-cell lymphomas.","volume":"113","author":"Novak","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111818203125500_B33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1525-1578(10)60525-9","article-title":"Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.","volume":"6","author":"Tr\u00f8en","year":"2004","journal-title":"J Mol Diagn"},{"issue":"2","key":"2019111818203125500_B34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"issue":"58","key":"2019111818203125500_B35","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/onc.2008.333","article-title":"Repression of E-cadherin by the polycomb group protein EZH2 in cancer.","volume":"27","author":"Cao","year":"2008","journal-title":"Oncogene"},{"issue":"20","key":"2019111818203125500_B36","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1093\/emboj\/cdg542","article-title":"EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.","volume":"22","author":"Bracken","year":"2003","journal-title":"EMBO J"},{"issue":"12","key":"2019111818203125500_B37","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4161\/epi.26546","article-title":"A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma.","volume":"8","author":"Kanduri","year":"2013","journal-title":"Epigenetics"},{"issue":"9","key":"2019111818203125500_B38","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2009-12-256446","article-title":"KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.","volume":"116","author":"Guan","year":"2010","journal-title":"Blood"},{"issue":"8","key":"2019111818203125500_B39","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3109\/10428194.2013.848437","article-title":"Expression of KLF4 is a predictive marker for survival in pediatric Burkitt lymphoma.","volume":"55","author":"Valencia-Hip\u00f3lito","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2019111818203125500_B40","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s12192-010-0199-5","article-title":"KLF4 promotes hydrogen-peroxide-induced apoptosis of chronic myeloid leukemia cells involving the bcl-2\/bax pathway.","volume":"15","author":"Li","year":"2010","journal-title":"Cell Stress Chaperones"},{"issue":"5","key":"2019111818203125500_B41","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.humpath.2005.03.004","article-title":"Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas.","volume":"36","author":"Thompson","year":"2005","journal-title":"Hum Pathol"},{"issue":"5","key":"2019111818203125500_B42","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1128\/MCB.15.5.2672","article-title":"Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6.","volume":"15","author":"Hirai","year":"1995","journal-title":"Mol Cell Biol"},{"key":"2019111818203125500_B43","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/271347","article-title":"RUNX family participates in the regulation of p53-dependent DNA damage response.","volume-title":"Int J Genomics","author":"Ozaki","year":"2013"},{"issue":"5189","key":"2019111818203125500_B44","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.7973727","article-title":"Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen.","volume":"266","author":"Smith","year":"1994","journal-title":"Science"},{"issue":"5","key":"2019111818203125500_B45","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1634\/theoncologist.2012-0465","article-title":"Concise drug review: azacitidine and decitabine.","volume":"18","author":"Derissen","year":"2013","journal-title":"Oncologist"},{"key":"2019111818203125500_B46","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-14-1561","article-title":"The BET Bromodomain inhibitor OTX015 affects pathogenetic pathways in pre-clinical B-cell tumor models and synergizes with targeted drugs.","author":"Boi","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2019111818203125500_B47","article-title":"Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of CDKN1A expression levels in mediating their anti-tumor response.","volume-title":"Oncotarget","author":"Mensah","year":"2014"},{"key":"2019111818203125500_B48","article-title":"Preclinical antitumor activity of ST7612AA1: a novel second generation oral histone deacetylase (HDAC) inhibitor.","author":"Vesci","year":"2014","journal-title":"Oncotarget"},{"issue":"1","key":"2019111818203125500_B49","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1200\/JCO.2012.42.7906","article-title":"Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed\/refractory B-cell malignancies.","volume":"31","author":"Advani","year":"2013","journal-title":"J Clin Oncol"},{"issue":"22","key":"2019111818203125500_B50","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1182\/blood-2013-11-538546","article-title":"Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-\u03b4, as therapy for previously treated indolent non-Hodgkin lymphoma.","volume":"123","author":"Flinn","year":"2014","journal-title":"Blood"},{"issue":"3","key":"2019111818203125500_B51","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1182\/blood-2009-08-233155","article-title":"Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma.","volume":"115","author":"Di Bella","year":"2010","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/125\/12\/1922\/1383100\/1922.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/125\/12\/1922\/1383100\/1922.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T19:24:31Z","timestamp":1717701871000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/125\/12\/1922\/33705\/DNA-methylation-profiling-identifies-two-splenic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,19]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,3,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2014-08-596247","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,19]]}}}